Skip to main content
. 2021 Feb 26;12(3):430–438. doi: 10.1039/d0md00436g
A549 A431
10 62.09 ± 3.30 28.49 ± 0.46 >100
25 16.30 ± 0.78 8.04 ± 0.90c >100
Erlotinib 47.74 ± 6.96 28.70 ± 6.47 >6
a

Data are shown as means ± SEM (n = 3) and ND; not detected.

b

p ≤ 0.001 vs. ruxolitinib.

c

p ≤ 0.05 vs. erlotinib.